HIV trials in Mexico
10 of 13 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- Where
- Guadajalara, Mérida, Mexico City, San Pedro Garza García
- Age
- 12 years and over
- People
- 564 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00 - No phaseEnrolling by invitationEffect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy
- Where
- Mexico City
- Age
- 18 years and over
- People
- 92
- Run by
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
See details and how to joinNCT06971445 - Phase 2/3Taking peopleA Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Where
- León, Veracruz
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07266831 · EU 2025-522519-40-00 - Phase 2Taking peopleDoravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Where
- Coyoacán, Mérida, Mexico City
- Age
- 4 weeks to 11 years
- People
- 84 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04375800 - Phase 4Taking peopleEffectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up
- Where
- Mexico City
- Age
- 18 years and over
- People
- 78
- Run by
- Instituto Mexicano del Seguro Social
See details and how to joinNCT07678268 - No phaseEnrolling by invitationShort-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS
- Where
- México
- Age
- 18 years to 80 years
- People
- 196
- Run by
- Centro de Investigación en. Enfermedades Infecciosas, Mexico
See details and how to joinNCT03856229 - Phase 3Taking peopleDOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity
- Where
- Mexico City
- Age
- 18 years to 70 years
- People
- 306
- Run by
- José Antonio Mata Marín
See details and how to joinNCT07075146 - Phase 4Taking peopleEfficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
- Where
- Mexico City
- Age
- 18 years to 70 years
- People
- 156
- Run by
- José Antonio Mata Marín
See details and how to joinNCT07138144 - Phase 4Taking peopleSafety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
- Where
- Mexico City
- Age
- 18 years and over
- People
- 124
- Run by
- Instituto Mexicano del Seguro Social
See details and how to joinNCT07031063 - Phase 4Taking peopleEffectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
- Where
- Mexico City
- Age
- 18 years to 70 years
- People
- 138
- Run by
- José Antonio Mata Marín
See details and how to joinNCT06907056